April 8 was the last update on clinical trials site to change status to recruiting. Six week stabilisation period. 20th May is 6 weeks.
So from tomorrow could hear of patients dosing, but doubt they would recruit on day 1.
- Forums
- ASX - By Stock
- DXB
- Ann: FDA IND Approval for Phase 3 Study of DMX-200 in FSGS
Ann: FDA IND Approval for Phase 3 Study of DMX-200 in FSGS, page-13
-
-
- There are more pages in this discussion • 37 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add DXB (ASX) to my watchlist
(20min delay)
|
|||||
Last
45.5¢ |
Change
0.015(3.41%) |
Mkt cap ! $250.3M |
Open | High | Low | Value | Volume |
45.0¢ | 46.5¢ | 44.0¢ | $1.039M | 2.304M |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
9 | 108833 | 45.0¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
46.0¢ | 69774 | 8 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
9 | 108833 | 0.450 |
5 | 69587 | 0.445 |
8 | 156416 | 0.440 |
7 | 564893 | 0.435 |
7 | 152816 | 0.430 |
Price($) | Vol. | No. |
---|---|---|
0.460 | 69774 | 8 |
0.465 | 53277 | 4 |
0.470 | 63782 | 6 |
0.475 | 57968 | 5 |
0.480 | 47062 | 4 |
Last trade - 13.37pm 09/07/2024 (20 minute delay) ? |
Featured News
DXB (ASX) Chart |